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Peter Jukkola1, Tomas Guerrero2, Victoria Gray3 and Chen Gu1,4*Abstract
Background: Neuronal activity intimately communicates with blood flow through the blood–brain barrier (BBB)
in the central nervous system (CNS). Astrocyte endfeet cover more than 90% of brain capillaries and interact with
synapses and nodes of Ranvier. The roles of astrocytes in neurovascular coupling in the CNS remain poorly understood.
Results: Here we show that astrocytes that are intrinsically different are activated by inflammatory autoimmune insults
and alterations of neuronal activity. In the progression of experimental autoimmune encephalomyelitis (EAE), both
fibrous and protoplasmic astrocytes were broadly and reversibly activated in the brain and spinal cord, indicated by
marked upregulation of glial fibrillary acidic protein (GFAP) and other astrocytic proteins. In early and remitting EAE,
upregulated GFAP and astrocytic endfoot water channel aquaporin 4 (AQP4) enclosed white matter lesions in spinal
cord, whereas they markedly increased and formed bundles in exacerbated lesions in late EAE. In cerebellar cortex,
upregulation of astrocytic proteins correlated with EAE severity. On the other hand, protoplasmic astrocytes were also
markedly activated in the brains of ankyrin-G (AnkG) and Kv3.1 KO mice, where neuronal activities are altered. Massive
astrocytes replaced degenerated Purkinje neurons in AnkG KO mice. In Kv3.1 KO mice, GFAP staining significantly
increased in cerebellar cortex, where Kv3.1 is normally highly expressed, but displayed in a patchy pattern in parts of
the hippocampus.
Conclusions: Thus, astrocytes can detect changes in both blood and neurons, which supports their central role in
neurovascular coupling. These studies contribute to the development of new strategies of neuroprotection and repair
for various diseases, through activity-dependent regulation of neurovascular coupling.
Keywords: Experimental autoimmune encephalomyelitis, Astrocytic endfeet, Water channel, Neurovascular coupling,
Ankyrin-G, Voltage-gated potassium (Kv) channelBackground
Normal functions of the CNS rely critically on the
proper structure and function of the vascular system.
Blood vessels provide neurons with oxygen and nutrients
and protect them from toxins and pathogens. Neurons,
in turn, control blood vessel dilation and contraction.
The neurovascular unit consists of neurons, glia (astro-
cytes, microglia and oligodendrocytes), and vascular
cells (endothelia, pericytes and smooth muscle cells).* Correspondence: gu.49@osu.edu
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reproduction in any medium, provided the orVascular cells form the BBB and maintain the chemical
and cellular composition of the neuronal microenviron-
ment, which is required for proper functioning of neuronal
synapses and circuits. Emerging evidence shows some
neurodegenerative diseases, such as Alzheimer’s disease,
amyotrophic lateral sclerosis, and multiple sclerosis (MS),
are initiated and perpetuated by vascular abnormalities
[1-3]. Understanding neurovascular coupling will advance
the diagnosis, therapy, and prevention of these diseases.
Astrocytes play a key role in neurovascular coupling.
Astrocytes outnumber neurons in human brain and
spinal cord [4] and fulfill important roles in regulating
synapse formation and function [5], and axon myelination
[6,7], as well as neurovascular coupling [8]. They are a
diverse group of cells in the CNS and can be dividedLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in gray matter and their endfoot processes ensheath
synapses. Fibrous astrocytes reside in white matter and
their endfeet contact myelin membranes and nodes of
Ranvier [9]. Endfeet of both types of astrocytes cover
more than 90% of brain capillaries [9,10].
MS is an inflammatory demyelinating disease with
unknown origin. In brain biopsies of MS patients, lesions
are characterized by extensive loss of myelin, axonal
damage and inflammation [11-14]. Activation of immune
cells and disruption of the BBB are early events in MS
pathology and have been extensively studied, but the role
of astrocytes in MS progression is relatively unexplored
[12]. GFAP was isolated from old MS plaques in 1971
[15]. However, astrocytes only began to gain attention
in MS recently due to two channel proteins that are
expressed at astrocytic endfeet. The water channel AQP4
regulates water balance, and its auto-antibody can lead
to neuromyelitis optica (NMO) [16-18], arguably con-
sidered as a variant of MS [19]. In the CNS, AQP4 is
predominantly localized to astrocytic endfeet contacting
blood capillaries. In NMO, astrocytic AQP4 is the primary
target of an immune response that results in profound
damage to astrocytes, breakdown of the BBB, secondary
loss of myelin, and apoptosis of oligodendrocytes
[12,17,20]. An inwardly rectifying K+ channel, Kir4.1,
is also present in astrocytic endfeet, and is involved in
K+ buffering [21-23]. Kir4.1 is likely a target of the
autoimmune response in a subgroup of MS patients
[24]. Our previous studies show that astrocytes in
spinal cord white matter are activated during EAE, an
animal model for MS [25]. Kv1.4 is upregulated in
astrocytes during EAE [25]. How astrocytes are altered
in different brain regions is not known. In the past,
the astrocyte has been viewed as a cell that promotes
inflammation and forms glial scars that hinder remyelina-
tion and axon growth. We now know that astrocytes can
enhance CNS myelination by promoting the migration,
proliferation, and differentiation of oligodendrocyte
progenitor cells. Promotion of CNS myelination by
astrocytes has been demonstrated in many culture models
[6,7,26,27].
Astrocytes express neurotransmitter receptors that allow
them to respond to neuronal activity [28]. Astrocytes
are activated in epilepsy and ataxia, diseases often
caused by imbalances of excitatory and inhibitory neural
networks. Glutamate receptors and transporters expressed
on astrocytes are altered in epilepsy [29], while a key
enzyme in the glutamate cycle, glutamine synthetase, is
down-regulated [30,31]. AQP4 polarization to astrocytic
endfeet was disrupted in the latent phase of the kainate
model of epilepsy, before the onset of spontaneous seizure
activity [32]. Astrocyte dysfunction and alterations are
involved in other neurodegenerative diseases, including thespinocerebellar ataxia by Ataxin-7 mutant [33]. Therefore,
astrocytes play a key role in mediating neurovascular coup-
ling. A better understanding of alterations to neurovascular
units in different regions and in response to different
stimuli will contribute to our understanding of (1) why
certain brain regions are vulnerable to specific insults
in certain neurological diseases, and (2) how CNS lesions
initiate, extend, and repair in terms of neurons and glia.
In this study, we systematically examined alterations
of astrocytic proteins on animal models for different
diseases, including MS, neurodegenerative ataxia and
epilepsy. Astrocytes are broadly activated in the CNS
including both spinal cord and brain by autoimmune
inflammation in EAE. On the other hand, altered neuronal
activity, particularly synaptic activity, can also activate
astrocytes. Thus, astrocytes are a good indicator for
alterations in neurovascular coupling and a mediator of the
vicious cycles in a number of neurodegenerative diseases.
Methods
Reagents and antibodies
The nuclear dye (Hoechst 33342) and the lipophilic
dyes (Fluoromyelin-green and Fluoromyelin-red) were
purchased from Invitrogen (Carlsbad, CA, USA). The
following antibodies were used in our study: rabbit poly-
clonal anti-Kv1.4, anti-AQP4 (Alomone Labs, Jerusalem,
Israel), and anti-PKCγ (Santa Cruz Biotechnology, Dallas,
TX); goat polyclonal anti-GFAP (AbCAM, Cambridge,
MA, USA); chicken polyclonal anti-Vimentin (Millipore,
Temecula, CA); and Dylight 488-, Dylight 649-, Cy3-, and
Cy5-conjugated secondary antibodies (Jackson Immuno
Research Laboratories, West Grove, PA, USA). Myelin
oligodendrocyte glycoprotein (MOG) peptide 35–55
(MEVGWYRSPFSRVVHLYRNGK) was purchased from
Pro-Spec (Rehovot, Israel), and proteolipoprotein (PLP)
peptide 139–151 (HCLGKWLGHPDKF) from Anaspec
(Fremont, CA, USA). Ground inactivated mycobacteria
tuberculosis H37Ra and Incomplete Freund’s Adjuvant
were from Difco Laboratories (Detroit, MI, USA).
Induction of chronic EAE
Chronic EAE was induced in 12-week-old female C57BL/
6 and Thy1:YFP transgenic mice (Jackson Laboratories,
Bar Harbor, ME, USA) according to previously published
methods [25]. Briefly, myelin oligodendrocyte glycoprotein
(MOG) peptide 35–55 (1 mg/mL final concentration) was
emulsified in sterile-filtered PBS and Complete Freund’s
Adjuvant (CFA) containing 2 mg/mL (final concentration)
ground inactivated mycobacteria tuberculosis H37Ra.
Mice were immunized with 100 μL of MOG/CFA or
CFA only (control) by subcutaneous injection at four
sites in the belly and in each hind footpad. Pertussis
toxin was administered by tail-vein injection at 0 and
2 days post immunization (DPI). Disease progression
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6 [0 = no symptoms, 1 = loss of tail tone, 2 = hindlimb
paresis, 3 = moderate paralysis, 4 = paraplegia (complete
hindlimb paralysis), 5 = quadriplegia, 6 = death or moribund
state]. Grade 6 animals were removed from the study.
Induction of remitting-relapsing EAE
As previously published [25], procedures for the induction
and monitoring of rrEAE in 12-week-old female SJL/J
mice (Jackson Laboratories) were identical to chEAE
procedures except for the use of a different myelin peptide,
PLP 139–151.
Cardiac perfusion, tissue fixation and sectioning
Animal tissues were collected and processed according to
previously published methods, with minor modification
[25]. Briefly, mice were deeply anesthetized with avertin
and perfused through the heart with 20–30 mL ice-cold
PBS followed by 20 mL 4% formaldehyde in PBS (FA/
PBS). The brain and spinal cord of EAE mice were
carefully removed and post-fixed overnight in 4% FA/
PBS. Wildtype, AnkG−/−, and Kv3.1−/− mice were
post-fixed in 4% FA/PBS for just 1 h, which allowed
improved staining resolution of fine astrocyte processes.
Tissues were cryoprotected in 30% sucrose for at least
24 hr, cut into 3-mm blocks using an acrylic brain matrix
(Braintree Scientific, Braintree, MA, USA), embedded in
optimal cutting temperature (OCT) media (Sakura Finetek
USA, Inc., Torrance, CA, USA), and stored at −80°C until
sectioning. The tissue blocks were cut with a Microm
HM550 cryostat (Thermo Scientific, Waltham, MA, USA)
and the 40-μm sections were collected on Superfrost Plus
microscope slides (FisherScientific, Pittsburgh, PA, USA)
for storage at −20°C.
Immunofluorescent staining
Tissues were stained according to previously published
methods [25], with minor modification. Briefly, sections
were permeabilized in PBS/0.4% Triton X-100 for 1 hr
at room temperature (RT), blocked with 2.5% normal
donkey serum for 1 hr at RT, and incubated in primary
antibodies in blocking solution for 3 hr at RT and over-
night at 4°C. The next day, the sections were rinsed
10 × 5 min, incubated for 3 hr with secondary anti-
bodies in blocking solution, counterstained in Hoechst
33342 and/or Fluoromyelin for 10 min, and again rinsed
10 × 5 min (all at RT). Slides were coverslipped using
tris-buffered Fluoro-Gel mounting media (Electron
Microscopy Sciences, Hatfield, PA, USA). Staining for
each primary antibody was performed at least twice on
tissue from 3–6 mice per experimental cohort, except
for the late RREAE cohort in which only 2 mice were
available.Fluorescence light microscope and image capture
Fluorescence microscopy and image analysis procedures
were adapted from previously published methods [25,34,35].
Images were captured with a Spot CCD camera RT slider
(Diagnostic Instruments, Sterling Heights, MI, USA) in
a Zeiss Axiophot upright microscope using10×/0.30
and 20×/0.50 Plan Apo objectives and saved as 16-bit
TIFF files. Exposure times were controlled so that the
pixel intensities in the tissues of interest were below
saturation, and the same exposure time was used for
each group within an experiment. Image brightness and
contrast were adjusted using Adobe Photoshop 7.0
(Adobe Systems Incorporated, San Jose, CA, USA).
Images to be quantified were chosen from 2 representa-
tive experiments for each antibody, and compared between
experimental cohorts (3 mice quantified per cohort). The
number of images quantified is noted on the bar graphs
in each figure. Images were analyzed with MetaMorph
(Molecular Devices, Downingtown, PA, USA) and Sig-
maplot 11.0 (Systat Software, Inc., Chicago, IL, USA)
for fluorescence intensity quantification and statistical
testing. Staining intensities for GFAP, Vimentin, Kv1.4,
and AQP4 were measured by using the MetaMorph
region measurement tool to sample and automatically
calculate the average pixel fluorescence intensities of
small circles (~ 50-pixel area) drawn on astrocyte soma
and processes (10–20 sampled per image), and these
intensities were averaged for each image. The background
intensity of the slide was then measured and subtracted
from the astrocyte staining intensity for each image. To
account for variations in staining intensity from images
obtained in different staining experiments, the data were
normalized to controls stained side-by-side. The image
fluorescence intensity values were averaged to obtain the
mean fluorescence intensity for each experimental group,
expressed as mean ± SEM. These fluorescence intensity
measurements reflect the level of protein present within
the cells stained by a particular antibody (higher intensity
correlates with more protein), and do not give any
indication of lesion size or cell number. To quantify
cell numbers in hippocampus or cortex, the area of
the region of interest in each image was first measured
using the MetaMorph region measurement tool. Then,
the GFAP + cells present in these regions were counted
manually and expressed as the number of cells per mm2,
mean ± SEM. Statistical significance was determined
between two groups using an unpaired Student’s t test,
and among three or more groups using One-Way
ANOVA followed by Fisher’s test. Statistically significant
differences from the Control group (for EAE experiments)
or the Wildtype group (for KO mice) are shown by an
asterisk (*) in figures. All fluorescence intensity mea-
surements were taken from the originally captured
images.
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High-magnification confocal images were captured
with a Leica TCS SL confocal imaging system (Leica
Microsystems, Mannheim, Germany), using a 100×
HCX Plan Apo CS oil immersion objective (numerical
aperture = 1.40). Multiple channels were acquired sim-
ultaneously, or sequentially only if needed to eliminate
channel bleed-through. Channel bleed-through was largely
eliminated through optimization of the laser line intensity
by acousto-optical tunable excitation filters, and by
spectral detectors allowing precisely-defined bandwidth
adjustment. The signal was averaged over eight scans in
linescan mode. Images were saved as 8-bit TIFF files
and adjusted for brightness and contrast using Adobe
Photoshop 7.0.
For 3D reconstruction, z-stacks of images were collected
with a 0.5-μm slice interval. Collapsed images were
created using a maximum intensity projection of the
z-stack. For each 3D image, the z-stack was visualized in
three-dimensional cross section, and the cross-bars were
centered on pertinent features of the image. The three
one dimensional images were then exported together as
an 8-bit TIFF file. Supplemental movies were created
using the Maximum Projection with Animation tool
within the Leica Confocal Software (v2.61). A maximum
intensity projection of the z-stack was rotated 90 degrees
around the Y-axis in a series of 18 or 36 steps and
exported as an AVI file, and converted to an MPEG-1
file (MPG).AnkG and Kv3.1 KO mice
AnkG KO mice were previously published [36]. The
Kv3.1 knockout (KO) mouse line was kindly provided
by Dr. R. Joho at UT Southwestern Medical Center and
has been maintained using a PCR-based genotyping
procedure as previously described [37-39]. The Kv3.1 KO
mice were backcrossed with C57BL/6 for ten generations.
Although very rare, seizure convulsions (last only 10–
15 sec; mouse returns to normal within a few minutes)
can be observed occasionally from some Kv3.1 homozygote
(−/−) but not heterozygote (+/−) mice. The following
primers were used: forward primer 31 F775 (for both WT
and knockout, 5′- GCG CTT CAA CCC CAT CGT GAA
CAA GA -3′), reverse primer 31R991 (for WT, 5′- GGC
CAC AAA GTC AAT GAT ATT GAG GG -3′), and
reverse primer PNR278 (for knockout, 5′- CTA CTT
CCA TTT GTC ACG TCC TGC AC -3′). Three Kv3.1
KO (−/−) and three control C57BL/6 mice of either sex at
the age of 2–4 months were used in this study.
All animal experiments have been conducted in ac-
cordance with the NIH Animal Use Guidelines and were
approved by the Ohio State University Institutional Animal
Care and Use Committee (IACUC).Results
AQP4, Kv1.4, Vimentin and GFAP are upregulated in
SCWM at different stages of EAE
To understand how inflammatory autoimmune insults
affect astrocytes in the CNS, we performed the MOG35-55-
induced chronic EAE (chEAE) (Figure 1A), as previously
described [25]. First, we examined spinal cord white
matter (SCWM) and gray matter (SCGM). In SCWM of
control mice, AQP4 and Vimentin (Vim) were colocalized
in GFAP-positive astrocytes (Figure 1C,E). At the peak
stage of chEAE, GFAP was significantly upregulated
around demyelinated lesion sites, where AQP4 was also
upregulated (Figure 1D). The Kv1.4 level was upregulated
together with Vim around the lesion sites (Figure 1E,F).
Both GFAP and Vim are upregulated in reactive astro-
cytes. Although both are intermediate filaments, they
differ in temporal and spatial expression patterns in
astrocytes. Vim is expressed in radial glia and immature
astrocytes, as well as other cell types, whereas GFAP
replaces Vim in many mature astrocytes [40-42]. In adult
CNS, Vim expression may indicate astrocyte proliferation.
In the present study, we use it as a marker for distinct
subpopulations of astrocytes. In our recent study, we
found that Kv1.4 was upregulated in astrocytes of SCWM
near the EAE lesion sites [25], but not in astrocytes in
other regions of the CNS. Interestingly, both Kv1.4 and
Vim expression were upregulated in SCWM (Figure 1E,F).
Therefore, we examined Vim expression in other regions
of the CNS during EAE in following studies, which may
suggest potential astrocytic proliferation.
Using high magnification confocal imaging, we examined
alterations of the neurovascular unit (axons, astrocytes,
and capillaries) of Thy1-YFP transgenic mice. Axons
were revealed by YFP fluorescence, astrocytes were
stained for GFAP, and capillaries were revealed with
AQP4 staining. In control, fibrous astrocytes in SCWM
extended processes parallel with axons, while AQP4 in
astrocyte endfeet colocalized with putative nodes of Ranvier
along YFP-positive axons (Figure 1G and Additional file 1:
Movie S1). At the peak stage of chEAE, GFAP and AQP4
staining disappeared in the center of the lesion, but was
often upregulated surrounding lesion sites (Figure 1H and
Additional file 2: Movie S2). YFP-positive axons were often
fragmented near the lesion, indicating axonal degeneration
(Figure 1H and Additional file 2: Movie S2). EAE lesions
were only observed in WM but not in GM.
Differential alterations of myelin and astrocytes in the
late and remitting EAE in SCWM
We further compared altered protein expression in astro-
cytes at the late stage of chEAE and at the remitting stage
of remitting-relapsing EAE (rrEAE). In late chEAE, demye-
linated lesion areas were very extensive. Both AQP4 and
GFAP colocalized very well within and around the lesion
Figure 1 Activation of astrocytes in spinal cord white matter. A, Clinical scores (top) and body weight (bottom) of mice with chEAE. B,
White matter (WM) and gray matter (GM) in spinal cord longitudinal section was stained with FMG (green) and nuclear dye (blue). Box 1 shows
both GM and WM and box 2 shows only WM. Spinal cord sections, control (C) and EAE peak (D), were co-stained for GFAP (green, top), AQP4
(red), Hoechst (blue), and FMG (green, bottom). Co-staining of Kv1.4 (green, top), Vim (red), Hoechst (blue) and FMG (green, bottom) were also
performed on control (E) and EAE (F) spinal cord sections. High magnification confocal image stacks were obtained from control (G) and EAE
(H) Thy1-YFP transgenic mice. Images contain YFP (green), GFAP (blue) and AQP4 (red). The collapsed 2D image is on the left, and 3 cross
sections are on the right. In (G), the crossbars are centered on a putative node of Ranvier. In (H), the crossbars are centered on the AQP4+/GFAP + lesion
edge. Scale bars, 500 μm in C-F, 50 μm in G,H.
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increased in these dense astrocytic fibers (Figure 2B,E).
In contrast, lesions in remitting rrEAE were fewer and
much smaller, and enclosed by GFAP- and AQP4-positive
processes (Figure 2C). The increase of Kv1.4, Vim and
GFAP but not AQP4 levels were significant at the re-
mitting stage (Figure 2C,D,F). High magnification
confocal images revealed GFAP staining in extended
processes of astrocytes, colocalizing with AQP4 in lesion
sites at the late stage of chEAE (Figure 2G). In contrast,
at the remitting stage of rrEAE, a small lesion was
fully enclosed by GFAP- and AQP4-positive processes
(Figure 2H). This result indicates that activated astrocytes
may deter the infiltration, proliferation and migration of
immune cells to limit the lesion at the initial and remitting
stages of EAE.Cerebellar astrocytes are differentially activated at
different stages of EAE
EAE lesions were observed in cerebellar white matter,
especially in EAE mice with high clinical scores [25].
We wondered whether cerebellar gray matter including
various astrocytes is affected during EAE. In the cerebellum
of control mice, GFAP was expressed at relatively low
levels in WM (highest), granule cell layer (medium), and
molecular layer (lowest) (Bergmann glia). In the molecular
layer, Bergmann glia expressed both GFAP and Vim at
low levels, whereas protoplasmic astrocytes surrounding
Purkinje neuron soma expressed higher levels of GFAP
but with no expression of Vim (Figure 3A and Additional
file 3: Movie S3). AQP4 was expressed rather diffusedly
but concentrated around blood capillaries (Figure 3A
and Additional file 3: Movie S3). At the peak stage of
rrEAE, the GFAP level significantly increased in both
Bergmann glia and protoplasmic astrocytes (Figure 3B,H
and Additional file 4: Movie S4). At the remitting stage,
GFAP levels reduced (Figure 3C,H and Additional file 5:
Movie S5). At the relapsing stage, GFAP staining increased
again (Figure 3D,H and Additional file 6: Movie S6). The
Vim level in the Bergmann glia did not change much,
and it was not expressed in the protoplasmic astrocytes
(Figure 3). The AQP4 level only moderately increased
at the peak stage of rrEAE (Figure 3). Therefore, astrocytic
GFAP levels in cerebellar gray matter are altered during
EAE, in addition to the changes in cerebellar WM, where
EAE lesions were observed sometimes. The alterations
of neurovascular units in cerebellar WM were similar to
those of SCWM, except that all lesion sites in cerebellar
white matter were enclosed, overall smaller than those
in SCWM (Figure 3E,F). AQP4 was more concentrated
in the granule cell layer. Its expression increased around
lesions in cerebellar WM. In the molecular layer, its
expression was around the blood vessels.Fibrous GFAP + and AQP4+ processes, and axons were
observed in SCWM and white matter of cerebellum and
corpus callosum. Their organization is quite similar in all
of these areas. Although upregulation of GFAP was also
observed in corpus callosum, no lesion was observed there
at any stage of EAE (data not shown).
Hippocampal astrocytes are activated at the peak and
late stages of EAE
Although no lesion was clearly observed in the hippocam-
pus during the course of EAE, we surprisingly observed
the upregulation of GFAP staining in the hippocampus.
GFAP-positive protoplasmic astrocytes were observed in
the hippocampi of control mice, providing non-overlap-
ping but complete coverage of the entire hippocampus
(Figure 4A). During EAE, GFAP levels markedly increased,
while AQP4 levels did not change (Figure 4A). In contrast
to SCWM astrocytes and Bergmann glia, hippocampal
astrocytes normally do not express Vim, but during EAE
its expression level significantly increased (Figure 4B,C,F).
We further examined the changes of the neurovascular
unit within the hippocampus using the Thy1-YFP trans-
genic mice. In the control, the hippocampal neuron soma,
dendrites and axons were revealed by YFP fluorescence.
Astrocytes were stained with GFAP antibody, and AQP4
staining revealed ensheathed blood capillaries (Figure 4D
and Additional file 7: Movie S7). During EAE, neuronal
morphology including axons, dendrites and dendritic spines,
remained largely unchanged, whereas GFAP staining
markedly increased. The level of AQP4 did not change,
but perivascular GFAP astrocyte staining significantly
increased (Figure 4E and Additional file 8: Movie S8).
Cortical astrocytes are activated at the peak and late
stages of EAE
In the cortex of control mice, GFAP staining was relatively
weak, almost invisible in some areas. Like in the hippo-
campus, AQP4 staining was mainly concentrated around
small-diameter blood capillaries. At the peak stage of rrEAE,
GFAP markedly increased, whereas AQP4 did not appear
to change much. At the remitting stage of rrEAE, GFAP
staining was significantly increased. At the relapsing stage
of rrEAE, GFAP staining intensity further increased
(Figure 5A,B). Perivascular GFAP appeared increased
significantly (Figure 5A). There was no Vim staining in
the cortex, even in EAE progression, indicating that the
properties of cortical astrocytes are different from those
of hippocampal astrocytes, even though they are all
protoplasmic astrocytes in GM.
Next, we performed high-resolution confocal imaging
of the cortex using Thy1-YFP mice. The dendrites and
spines were clearly seen in cortical pyramidal neurons
(Figure 5D and Additional file 9: Movie S9). Astrocytes
and blood vessels intertwined with neurons. Dendritic
Figure 2 (See legend on next page.)
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Figure 2 Astrocytic proteins are altered in lesion sites of at the late stage of chEAE and at the remitting stage of rrEAE. A and B,
staining patterns of astrocytic proteins at the late stage of chEAE. C and D, staining pattern of astrocytic proteins at the remitting stage of rrEAE.
E, Summary of the alteration of astrocytic proteins in chEAE. F, Summary of the alteration of astrocytic proteins in rrEAE. The “n” number of
quantified images is provided for each bar. One-way ANOVA followed by Fisher’s test. Asterisk (*) shows significant difference from Control
staining intensity for each antibody, p < 0.05. G, High magnification view of a lesion site at the late stage of chEAE. H, Confocal images of a lesion
site at the remitting stage of rrEAE. Collapsed 2D image is on the top, and 3 cross sections are on the bottom. In (G), the crossbars are centered
on an astrocyte with colocalizing AQP4 and GFAP. In (H), the crossbars emphasize the absence of AQP4 and GFAP in the lesion core. Scale bars,
500 μm in A-D, 50 μm in G,H.
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possibly represented the synapse-ensheathing endfeet of
astrocytes. Astrocytic endfeet are known to colocalize with
synapses. Dendritic spines are the postsynaptic structures
of excitatory synapses. In the cortex of EAE mice,
dendritic branches and spines were not changed, but
GFAP intensity and the number of GFAP + astrocytes
increased (Figure 5B,C,E and Additional file 10: Movie
S10). In particular, the GFAP + processes surrounding
blood capillaries positive for AQP4 appeared to increase
significantly and capillaries appeared dilated (Figure 5E
and Additional file 10: Movie S10). Thus, cortical astro-
cytes in EAE are primarily altered at the perivascular
endfeet. The dendritic spines and surrounding AQP4
staining puncta do not appear to be altered (Figure 5D,E).
Astrocyte alterations in AnkG and Kv3.1 KO mice
To understand how neuronal activity regulates astrocyte
and BBB function, we focused our studies on AnkG
and Kv3.1 KO mice. Crucial for efficient initiation and
saltatory propagation of action potentials along myelinated
axons of vertebrates, Nav channels are clustered at the
axon initial segment and nodes of Ranvier [43,44]. The
clustering of Nav channels, as well as some K+ channels
and cell adhesion molecules at axon initial segments
and nodes, is mediated by AnkG [36,45-48]. AnkG links
these key membrane proteins to the actin cytoskeleton
via spectrins and functions as a gate to maintain the
axon-dendrite polarity [49,50]. Since most nodes in
cerebellar WM have no adaptor protein AnkG [36], the
clustering of Nav channels at these nodes is eliminated
and thereby nodal excitability is altered, which may
conversely impact the astrocytic endfeet around the
nodes. It has never been shown before how astrocytes
are altered in AnkG KO mice.
The Kv3 (Shaw) channel subfamily contains 4 members
(Kv3.1 to Kv3.4). Kv3.1 and Kv3.2 carry sustained currents,
while Kv3.3 and Kv3.4 carry transient currents. Kv3
channels play a critical role in rapid spiking of action
potentials in some neurons [51-53]. Axonal targeting
and unique channel biophysical properties of Kv3 chan-
nels—high activation threshold, fast activation/deactivation
kinetics—allow neurons to fire action potentials at high
frequency [51,54-59]. KO mice were generated to studythe functions of different Kv3 channels. Kv3.1 KO mice
are viable and fertile [37]. Their spontaneous locomotor
and exploratory activities remain unchanged, although
their coordinated motor skill and muscle contraction
are worsened. Kv3.1 is expressed in cerebellar granule
cells and deep nuclei neurons, which are critical for timing
or gait patterning in motor functions [38,60,61]. Kv3.1b
has also been shown to localize in some nodes of Ranvier
in spinal cord white matter [62]. We were interested to
determine how alteration of neuronal activity in the
absence of AnkG or Kv3.1 would affect astrocytes and
BBB function.
Since the AnkG KO is missing the AnkG isoform
primarily expressed in the cerebellum and Kv3.1 is highly
expressed in the granule cells in the cerebellum, we
focused our studies on the cerebellum. In AnkG KO
mice, GFAP was increased in the cerebellar molecular
layers, from high to low in the following order, molecular
layer, Purkinje cell layer, and granule cell layer. PKCγ in
WT mice labeled the Purkinje neurons including soma
and dendrites (Figure 6A and Additional file 11: Movie
S11). In the AnkG KO mice, dendritic branches of
some Purkinje neurons reduced, and some Purkinje
neurons were degenerated, where GFAP staining signals
markedly increased (Figure 6B and Additional file 12:
Movie S12). These signals likely result from both increased
GFAP expression and increased number of astrocytes.
The increased GFAP-positive astrocyte processes were
not as oriented as the regular Bergmann glia cells (Figure 6B
and Additional file 12: Movie S12). In Kv3.1 KO mice,
GFAP signal intensity also significantly increased in the
molecular layer of the cerebellum (Figure 6C,G and
Additional file 13: Movie S13). In summary, in the mo-
lecular layer both GFAP and AQP4 staining increased
in both AnkG and Kv3.1 KO mice (Figure 6G). We next
examined the granule cell layer. In AnkG KO mice,
GFAP and AQP4 staining in granule cell layer were
higher (Figure 6E,H). In Kv3.1 KO mice, both GFAP
and AQP4 staining was higher (Figure 6F,H).
Finally, we examined astrocytic proteins in the hip-
pocampus and cerebral cortex. In the hippocampi of
AnkG and Kv3.1 KO mice, GFAP staining intensity was
increased (Figure 7A-C and Additional file 14: Movie S14,
Additional file 15: Movie S15 and Additional file 16:
Figure 3 Differentially altered expression of astrocytic proteins in the cerebellum of EAE mice. A, The confocal image stack of cerebellar
molecular layer that was stained for GFAP (green), AQP4 (red) and Vim (blue) from a control mouse. Collapsed 2D image is on the left and 3
cross sections of 3D are on the right. B, The images at the peak stage of an rrEAE mouse. C, The images at the remitting stage of an rrEAE
mouse. D, The images at the relapsing stage of an rrEAE mouse. E, The confocal images of cerebellar WM from a Thy1-YFP transgenic mouse.
YFP (green), AQP4 (red) and GFAP (blue). In (A-E), the crossbars are centered on astrocytic endfeet with colocalizing AQP4 and GFAP. F, The
confocal images at the peak stage of chEAE. The crossbars show the lesion edge with upregulated AQP4 and GFAP. G, Structural diagram of
cerebellar cortex. H, Summary of changes of protein levels during rrEAE in cerebellar molecular layer. One-Way ANOVA followed by Fisher’s test. *,
significant difference from Control for each antibody, p < 0.05. The “n” number of quantified images is provided for each bar. Scale bars, 50 μm.
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Figure 4 Activation of astrocytes in the hippocampus of EAE mice. A, Increased GFAP but not AQP4 staining in the hippocampus of EAE mice.
B, Increased Vim staining in the hippocampus during EAE progression. C, Enlarged images of individual astrocytes in the hippocampus clearly show
the increase of Vim staining. High magnification confocal image stacks were obtained from control (D) and EAE (E) Thy1-YFP transgenic mice. Images
contain YFP (green), GFAP (blue) and AQP4 (red). The collapsed 2D image is on the left, and 3 cross sections are on the right. The crossbars reveal
astrocytic endfeet with colocalizing AQP4 and GFAP. F, Summary of the levels of astrocytic proteins at different stages during EAE progression.
One-Way ANOVA followed by Fisher’s test, *, significant difference from Control for each antibody, p < 0.01. G, GFAP + cell number was not changed
during EAE. The “n” number of quantified images is provided for each bar. Scale bars, 200 μm in A and B, 50 μm in D and E.
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AQP4 staining were found in Kv3.1 KO mice (Figure 7C),
potentially indicating the death of some astrocytes. In the
cortex of AnkG KO and Kv3.1 KO mice, GFAP staining
intensity was also increased, but in a non-uniform way
(Figure 7D-F and Additional file 17: Movie S17, Additional
file 18: Movie S18 and Additional file 19: Movie S19). The
density of the brain capillary network appeared increased
in both the hippocampus and cortex in Kv3.1 KO mice
(Figure 7C,F).Discussion
In this study, we show alterations of neurovascular units
in different regions of the brain and spinal cord in response
to inflammation and altered neuronal activity. The analysis
of neurovascular units has been carried out with high-
resolution confocal imaging and 3D reconstruction.
This study mainly focuses on astrocytic proteins and
provides subcellular structural details regarding disease
progression induced by either inflammatory insults or
neuronal defects. Our studies indicate striking intrinsic
heterogeneity of astrocytes in the CNS, which likely
underlies their differential responses to various stimuli
(Figure 8).Both fibrous and protoplasmic astrocytes are activated
during EAE, but only fibrous astrocytes are selectively
damaged around lesion sites
The organization of fibrous astrocyte, endfeet AQP4 and
axons is quite similar in the WM of spinal cord, cerebellum,
and corpus callosum. GFAP and AQP4 were upregulated
during EAE. During EAE progression, lesions were
observed in WM of spinal cord and cerebellum (Figures 1,
2 and 3), but not in corpus callosum (data not shown).
Dramatic reorganization of neurovascular units was
observed only in WM at or surrounding the lesion
sites, but not in gray matter (Figures 1, 2 and 3). Thus
fibrous astrocytes appeared to be specifically damaged
in inflammatory demyelination. Both axonal demyelination
and degeneration were observed in the EAE spinal
cord. At the remitting stage, the lesion size and number
were reduced in spinal cord, and the levels of GFAP
reduced in SCWM and cerebellar GM, but not cortical
GM (Figures 2, 3 and 5).Vim is an intermediate filament and one of the markers
for astrocytes. In control animals, Vim is expressed in
SCWM and cerebellar Bergmann glia, but not in SCGM,
cerebellar Purkinje and granule cell layers, hippocampus,
and cortex (Figures 1E, 3, 4 and 5). During EAE, the level
of Vim markedly increased in SCWM and hippocampus
(Figures 1 and 4). Its level increased moderately in cerebel-
lar Bergmann glia (Figure 3), and did not increase at all in
other layers of cerebellum, or in cortex (Figures 3 and 5).
This result shows that astrocytes that are intrinsically
different respond to inflammation differently. In particular,
our result that GFAP is upregulated in the hippocampus
during EAE is consistent with a recent study [63]. Our
finding that Vim is upregulated in hippocampal astrocytes
during EAE indicates a distinct region-specific alteration
in EAE. Taken together, our results add to the growing
body of evidence that the hippocampus is affected in EAE,
despite the lack of clear immune-cell mediated lesions
characteristic of spinal cord. Recent evidence shows that
in addition to astrocytes, microglia are activated in EAE
[64]. The hippocampal CA1 region decreases in volume in
EAE, with specific loss of GABAergic interneurons [65].
Synaptic function and immunostaining are also reduced
in EAE, and can be recovered with testosterone [66] or
estriol treatment [67], which are interesting results due
to the gender disparity in MS incidence. Because astrocyte
activation and changes in neuronal activity occur in EAE,
this could correlate with the role of astrocytes in response
to neuronal defects that we observed in AnkG−/− and
Kv3.1−/− mice.
Increased GFAP staining around blood vessels is
observed in EAE mice, which may reflect increased
proliferation of perivascular astrocytes in gray matter
in the brain. In a recent study using live, two-photon
imaging to investigate the astrocyte response to a
cortical stab-wound injury, a limited number of astrocytes
(~20%) were found to proliferate, but ~70-80% of these
were located immediately adjacent to blood vessels [68].
No astrocytes were found to migrate toward the lesion,
but some became polarized and extended GFAP + pro-
cesses toward the injury site [68]. It is unclear whether
these polarized processes contributed to increased staining
of perivascular astrocyte endfeet. Further study is needed
to elucidate the cytokines or other secreted factors that
may induce perivascular astrocyte proliferation, and how
Figure 5 Alteration of GFAP and AQP4 in the cortex of EAE mice. A, Alterations of astrocytic proteins in the cortex at different stages of
rrEAE. B, Summary of the alterations of intensities. C, Summary of increased GFAP + cells. (B, C) One-Way ANOVA followed by Fisher’s test. *,
significant difference from Control for each antibody, p < 0.05. **, significant difference from Control for each antibody, p < 0.01. The “n” number
of quantified images is provided for each bar. High magnification confocal image stacks were obtained from control (D) and EAE (E) Thy1-YFP
transgenic mice. Images contain YFP (green), GFAP (blue) and AQP4 (red). The collapsed 2D image is on the left, and 3 cross sections are on the
right. Scale bars, 200 μm in A, 50 μm in D and E.
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Figure 6 Upregulation of GFAP and AQP4 in the cerebellum in AnkG and Kv3.1 KO mice. A, High magnification image stacks of cerebellar
molecular layer stained with anti-PKCγ (green) and anti-GFAP (red) antibodies. The collapsed 2D image is on the left, and 3 cross sections are on
the right. B, Confocal image stacks from the AnkG KO mice. C, Confocal image stacks from the Kv3.1 KO mice. In (A,C), the crossbars reveal
radially oriented GFAP + Bergmann glial processes in (A) WT and (C) Kv3.1 KO mice. In (B), the crossbars are centered on highly upregulated
GFAP + astrocyte processes in the absence of Purkinje neurons in an AnkG KO mouse. D, A single confocal image of the granule cell layer in a
WT mouse. E, An image from the AnkG KO mice. F, An image from the Kv3.1 KO mice. G, Normalized fluorescence intensity in the molecular
layer. H, Normalized fluorescence intensity in the granule cell layer. (G, H) One-Way ANOVA followed by Fisher’s test. *, significant difference from
Wildtype for each antibody, p < 0.05. **, significant difference from Wildtype for each antibody, p < 0.01. The “n” number of quantified images is
provided for each bar. Scale bars, 50 μm.
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might correlate with the more general autoimmune insult
in EAE. An interesting candidate is interferon-γ, a cytokine
with major effects in MS and EAE [69] that has been
shown to increase astrocyte proliferation in vitro and
in vivo [70]. Moreover, a recent study indicates that in
normal physiological conditions astrocytic endfeet play
a major role in regulating the flow of cerebrospinal
fluid and solutes into the brain parenchyma, and that
AQP4 is important to this process [71]. It is possible
that perivascular astrocyte proliferation may augment the
astrocytic roles in fluid and solute handling and help to
prevent the leakage of the BBB during EAE progression.
The analysis of neurovascular units can provide more
details regarding damaged nerve tissues during the
progression of various neurological diseases. Although
lesions were not observed in EAE in gray matter,
astrocyte morphology did change, GFAP staining was
increased, and astrocytes proliferated, all of which may be
indicators of neuroprotective function of astrocytes.
Neuronal activity regulates astrocytic protein expression
Purkinje neuron degeneration was observed in AnkG
KO mice [36]. Highly ordered Bergmann glial processes
became irregular, and GFAP staining markedly increased
at the same time. The highest staining of GFAP was
often associated with the loss of Purkinje cells (Figure 6B
and Additional file 12: Movie S12). Kv3.1 is mainly
expressed in cerebellar molecular and granule cell layers
in WT mice. The highest upregulation of GFAP was
found in the molecular cell layers in Kv3.1 KO mice
(Figure 6C,F,H).
The patchy loss of AQP4 staining in the hippocampus
of Kv3.1 KO mice may indicate the loss of astrocytes.
Interestingly, this was not observed in AnkG KO mice
or EAE mice at any stage (Figure 7C). This phenomenon
of patchy AQP4 loss has been reported previously in the
spinal cord gray matter of mice injected with AQP4
autoantibody-positive serum from NMO patients [72],
but has not previously been reported in any KO mice.
Kv3.1 channels are expressed in parvalbumin-positive
fast spiking interneurons in the hippocampus, but it is
unclear how interneuronal dysfunction in the absence of
Kv3.1 could cause loss of astrocytes. A loss of astrocyteshas been observed in the pilocarpine-induced epilepsy
model [73], which is interesting because although very
rare, we did see occasional seizures in our Kv3.1 KO
mice. Indeed, synaptic transmission does appear to play
a major role in regulating astrocytic protein expression.
Differential localization of AQP4 in fibrous and
protoplasmic astrocytes
AQP4 were highly colocalized with GFAP + processes in
the WM, different from the pattern in the GM where it
is highly concentrated in astrocytic endfeet contacting
blood vessels. AQP4 expression increased in SCWM in
EAE, which is consistent with a recent study in EAE and
correlates with increased AQP4 levels previously shown
in MS patient tissues [74,75]. This contrasts with loss of
AQP4 expression in NMO, a demyelinating disease in
which AQP4 autoantibodies are not only a highly specific
biomarker for the disease, but are involved in disease
pathology as well [76], despite some controversy for the
latter [77]. In the early stage of NMO but not MS, AQP4
and GFAP are lost before the loss of MBP staining in
NMO lesions, which can occur in WM or GM in mainly
perivascular areas [78]. Patient MRIs also show that
NMO lesions occur in both WM and GM [79]. AQP4
autoantibody-induced demyelination is thought to
occur by oligodendrocyte apoptosis secondary to loss
of astrocytes and astrocytic trophic support [80,81].
The BBB is more severely disrupted in NMO than in
MS [82], but T cells are not required for lesion forma-
tion, as shown in mice administered IgG from NMO
patients [83]. EAE susceptibility is almost eliminated in
AQP4−/− mice [84,85], and secretion of proinflammatory
cytokines from AQP4 −/− astrocytes was reduced in vitro
[84]. However, AQP4 deficiency significantly increased the
extent of neuron loss, demyelination, and motor dysfunc-
tion in a spinal cord contusion injury model [86]. Taken
together, these results suggest that AQP4 facilitates disease
progression after breakdown of the BBB, but also has a
neuroprotective effect, both of which could be mediated
by the central role of astrocytes in neurovascular coupling.
Functional consequences of astrocyte activation
Astrocytes are emerging as an important player in MS,
amyotrophic lateral sclerosis, Alzheimer’s disease, epilepsy,
Figure 7 Altered astrocytes in the hippocampus and cortex in Kv3.1 KO mice. The confocal image stacks of hippocampus (A-C) and cortex
(D-F) were costained for GFAP (green) and AQP4 (red) from WT (A,D), AnkG KO (B,E) and Kv3.1 KO (C,F) mice. The collapsed 2D image is on the top
and 3 cross sections are at the bottom. The crossbars are centered on astrocyte endfeet with colocalizing AQP4 and GFAP. Scale bars, 100 μm.
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Figure 8 Diagram of regulation of fibrous and protoplasmic astrocytes by inflammation and neuronal activities. A, Fibrous astrocytes in
the WM with endfeet contacting blood capillaries and nodes of Ranvier. B, Protoplasmic astrocytes in the GM with endfeet contacting blood
capillaries and synapses.
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[87]. In response to a variety of CNS disorders and
pathologies, astrocytes undergo tremendous changes in
morphology and function, becoming activated or reactive
astrocytes. These changes, including both reversible and
irreversible ones, are not an all-or-none phenomenon, but
are finely graded in a context-dependent manner regulated
by specific signaling pathways [87]. Astrocytes exhibit
excitability mainly by increasing intracellular Ca2+ concen-
tration [88,89]. Astrocytes relay information to other cells
through gap junctions and by releasing gliotransmitters
[4,90-93]. Astrocytes promote myelination in response
to electrical activity by releasing the cytokine leukemia
inhibitor factor [26], or through other means, such as
by coating axons with myelin-promoting extracellular
matrix molecules, providing lipids for myelin synthesis,
or modulating electrical activity. Various factors produced
from astrocytes can also impact myelination [94], such
as platelet-derived growth factor, fibroblast growth factor,
ciliary neurotrophic factor, leukemia inhibitor factor, and
insulin-like growth factor, as well as gliotransmitters
including glutamate and ATP. Interestingly, some of
these factors can further stimulate astrocytes via a positive
feedback loop. Functional consequences and signaling
pathways of astrocyte activation will be interesting topics
for future studies in various diseases.Conclusions
Taken together, the analysis of neurovascular units can
provide more details regarding the progression of diseases
induced by either inflammatory insults or neuronal
dysfunction. High-resolution confocal imaging with
3D reconstruction is a powerful tool to illustrate the
changes under abnormal conditions. Better understanding
their roles contributes to the development of novel strat-
egies of neuroprotection and repair for various diseases,
through activity-dependent regulation of neurovascular
coupling.
Additional files
Additional file 1: Movie S1. An image stack from a longitudinal
section of SCWM of a control Thy1-YFP mouse. YFP labels a subset of
axons. GFAP staining is in blue and AQP4 staining in red. This is the
supplemental movie for Figure 1G.
Additional file 2: Movie S2. An image stack from a longitudinal
section of SCWM of an EAE Thy1-YFP mouse. YFP labels a subset of
axons. GFAP staining is in blue and AQP4 staining in red. This is the
supplemental movie for Figure 1H.
Additional file 3: Movie S3. An image stack from a coronal section of
the cerebellar molecular layer in a control mouse. GFAP staining is in green,
AQP4 staining in red and Vim staining in blue. This is the supplemental
movie for Figure 3A.
Additional file 4: Movie S4. An image stack from a coronal section of
the cerebellar molecular layer at the peak stage of rrEAE. GFAP staining is
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supplemental movie for Figure 3B.
Additional file 5: Movie S5. An image stack from a coronal section of
the cerebellar molecular layer at the remitting stage of rrEAE. GFAP
staining is in green, AQP4 staining in red and Vim staining in blue. This is
the supplemental movie for Figure 3C.
Additional file 6: Movie S6. An image stack from a coronal section of
the cerebellar molecular layer at the relapsing stage of rrEAE. GFAP
staining is in green, AQP4 staining in red and Vim staining in blue. This is
the supplemental movie for Figure 3D.
Additional file 7: Movie S7. An image stack from a coronal section of
the hippocampus in a control Thy1-YFP transgenic mouse. YFP
fluorescence is in green, AQP4 staining in red and GFAP staining in blue.
This is the supplemental movie for Figure 4D.
Additional file 8: Movie S8. An image stack from a coronal section of
the hippocampus in a Thy1-YFP transgenic mouse at the peak stage of
chEAE. YFP fluorescence is in green, AQP4 staining in red and GFAP
staining in blue. This is the supplemental movie for Figure 4E.
Additional file 9: Movie S9. An image stack from a coronal section of
the cerebral cortex in a control Thy1-YFP transgenic mouse. YFP
fluorescence is in green, AQP4 staining in red and GFAP staining in blue.
This is the supplemental movie for Figure 5D.
Additional file 10: Movie S10. An image stack from a coronal section
of the cerebral cortex in a Thy1-YFP transgenic mouse at the peak stage
of chEAE. YFP fluorescence is in green, AQP4 staining in red and GFAP
staining in blue. This is the supplemental movie for Figure 5E.
Additional file 11: Movie S11. An image stack from a coronal section
of the molecular layer of cerebellar cortex in a WT mouse. PKCγ staining
is in green and GFAP staining in red. This is the supplemental movie for
Figure 6A.
Additional file 12: Movie S12. An image stack from a coronal section
of the molecular layer of cerebellar cortex in an AnkG KO mouse. PKCγ
staining is in green and GFAP staining in red. This is the supplemental
movie for Figure 6B.
Additional file 13: Movie S13. An image stack from a coronal section
of the molecular layer of cerebellar cortex in a Kv3.1 KO mouse. PKCγ
staining is in green and GFAP staining in red. This is the supplemental
movie for Figure 6C.
Additional file 14: Movie S14. An image stack from a coronal section
of the hippocampus in a WT mouse. GFAP staining is in green and AQP4
staining in red. This is the supplemental movie for Figure 7A.
Additional file 15: Movie S15. An image stack from a coronal section
of the hippocampus in an AnkG KO mouse. GFAP staining is in green
and AQP4 staining in red. This is the supplemental movie for Figure 7B.
Additional file 16: Movie S16. An image stack from a coronal section
of the hippocampus in a Kv3.1 KO mouse. GFAP staining is in green and
AQP4 staining in red. This is the supplemental movie for Figure 7C.
Additional file 17: Movie S17. An image stack from a coronal section
of the cerebral cortex in a WT mouse. GFAP staining is in green and
AQP4 staining in red. This is the supplemental movie for Figure 7D.
Additional file 18: Movie S18. An image stack from a coronal section
of the cerebral cortex in an AnkG KO mouse. GFAP staining is in green
and AQP4 staining in red. This is the supplemental movie for Figure 7E.
Additional file 19: Movie S19. An image stack from a coronal section
of the cerebral cortex in a Kv3.1 KO mouse. GFAP staining is in green and
AQP4 staining in red. This is the supplemental movie for Figure 7F.Competing interests
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